,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,21,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
11,23,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
12,25,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
13,27,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
14,29,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
15,31,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
16,33,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
17,35,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
18,37,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
19,39,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
20,41,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
21,43,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
22,45,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
23,47,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
24,49,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
25,51,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
26,53,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
27,55,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
28,57,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
29,59,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
30,61,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
31,63,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
32,65,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
33,67,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
34,69,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
35,71,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
36,73,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
37,75,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
38,77,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
39,79,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
40,81,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
41,83,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
42,85,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
43,87,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
44,89,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
45,91,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
46,93,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
47,95,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
48,97,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
49,99,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
50,101,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
51,103,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
52,105,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
53,107,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
54,109,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
55,113,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
56,115,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
57,119,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
58,121,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
59,123,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
60,125,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
61,129,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
62,131,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
63,133,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
64,135,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
65,137,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
66,139,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
67,141,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
68,143,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
69,145,1,1,,76734,3884,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
70,155,1,1,,76734,3884,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
71,157,1,1,,76734,3884,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
72,161,1,1,,76734,3884,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
73,165,1,1,,76734,3884,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
74,167,1,1,,76734,3884,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
75,175,1,1,,76734,3884,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
76,179,1,1,,76734,3884,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
77,179,1,1,,494718,3884,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
78,192,1,1,,76734,3884,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
79,196,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice,Other,,
80,222,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in C57BL/6 mice,Other,,
81,226,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in B6C3F1 mice,Other,,
82,248,1,1,,76734,3884,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
83,260,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
84,270,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
85,316,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
86,328,1,1,,76734,3884,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
87,330,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
88,334,1,1,,76734,3884,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
89,342,1,1,,76734,3884,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma 180 (subcutaneous) in Swiss mice,Other,,
90,608,1,6,,11537686,3884,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
91,875,1,2,,26748554,3884,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
92,880,2,1,,26748554,3884,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
93,880,2,1,,26748554,3884,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
94,880,2,1,,50107431,3884,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
95,880,2,1,,50107431,3884,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
96,881,2,2,,26748554,3884,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
97,884,1,2,,26748554,3884,Inconclusive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
98,885,1,2,,26748554,3884,Inactive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
99,887,1,2,,26748554,3884,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
100,889,1,3,,26748554,3884,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
101,892,1,2,,26748554,3884,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
102,893,1,2,,26748554,3884,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
103,893,1,2,,26748554,3884,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
104,894,2,1,,26748554,3884,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
105,894,2,1,,50107431,3884,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
106,900,1,3,,26748554,3884,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
107,902,1,2,,26748554,3884,Inconclusive,120407068.0,7157.0,2.5119,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
108,910,1,2,,26748554,3884,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
109,923,1,2,,26748554,3884,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
110,924,1,2,,26748554,3884,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
111,927,1,3,,26748554,3884,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
112,930,1,2,,26748554,3884,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
113,940,1,2,,26612236,3884,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
114,995,1,2,,26748554,3884,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
115,1030,2,1,,26748554,3884,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
116,1030,2,1,,50107431,3884,Inconclusive,30582681.0,216.0,28.1838,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
117,1033,2,2,,11537686,3884,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
118,1379,1,2,,26748554,3884,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
119,1379,1,2,,50107431,3884,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
120,1422,1,1,,26612236,3884,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
121,1452,1,1,,26748554,3884,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
122,1454,1,1,,26748554,3884,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
123,1454,1,1,,50107431,3884,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
124,1457,1,1,,26748554,3884,Inactive,44888968.0,83523.0,12.5893,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
125,1457,1,1,,50107431,3884,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
126,1458,1,1,,26748554,3884,Inconclusive,10937869.0,6607.0,3.1623,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
127,1458,1,1,,50107431,3884,Active,10937869.0,6607.0,3.9811,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
128,1460,1,3,,26748554,3884,Inconclusive,92096784.0,4137.0,19.9526,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
129,1460,1,3,,50107431,3884,Active,92096784.0,4137.0,28.1838,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
130,1463,1,1,,26748554,3884,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
131,1463,1,1,,50107431,3884,Inconclusive,,,19.9526,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
132,1467,1,3,,26748554,3884,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
133,1467,1,3,,50107431,3884,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
134,1468,1,1,,26748554,3884,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
135,1468,1,1,,50107431,3884,Inconclusive,92096784.0,4137.0,17.7828,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
136,1469,1,1,,26748554,3884,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
137,1469,1,1,,50107431,3884,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
138,1471,2,1,,26748554,3884,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
139,1471,2,1,,50107431,3884,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
140,1476,2,1,,26748554,3884,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
141,1476,2,1,,50107431,3884,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
142,1477,1,1,,26748554,3884,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
143,1477,1,1,,50107431,3884,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
144,1478,2,1,,26748554,3884,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
145,1478,2,1,,50107431,3884,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
146,1479,1,2,,26748554,3884,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
147,1479,1,2,,50107431,3884,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
148,1490,2,1,,26748554,3884,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
149,1490,2,1,,50107431,3884,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
150,1519,1,3,,26748554,3884,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
151,1549,1,2,,11537686,3884,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
152,1552,1,3,,11537686,3884,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
153,1580,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
154,1581,1,1,,8149780,3884,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
155,1582,1,1,,8149780,3884,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
156,1583,1,1,,8149780,3884,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
157,1584,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
158,1585,1,1,,8149780,3884,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
159,1586,1,1,,8149780,3884,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
160,1587,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
161,1588,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
162,1589,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
163,1590,1,1,,8149780,3884,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
164,1593,1,1,,8149780,3884,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
165,1594,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
166,1595,1,1,,8149780,3884,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
167,1596,1,1,,8149780,3884,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
168,1597,1,1,,8149780,3884,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
169,1598,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
170,1599,1,1,,8149780,3884,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
171,1600,1,1,,8149780,3884,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
172,1601,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
173,1602,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
174,1603,1,1,,8149780,3884,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
175,1604,1,1,,8149780,3884,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
176,1605,1,1,,8149780,3884,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
177,1606,1,1,,8149780,3884,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
178,1607,1,1,,8149780,3884,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
179,1608,1,1,,8149780,3884,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
180,1609,1,1,,8149780,3884,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
181,1610,1,1,,8149780,3884,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
182,1612,1,1,,8149780,3884,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
183,1613,1,1,,8149780,3884,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
184,1614,1,1,,8149780,3884,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
185,1616,1,1,,8149780,3884,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
186,1637,1,2,,11537686,3884,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
187,1648,1,2,,11537686,3884,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
188,1766,1,1,,26748554,3884,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
189,1766,1,1,,26748554,3884,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
190,1766,1,1,,50107431,3884,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
191,1766,1,1,,50107431,3884,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
192,1768,1,1,,26748554,3884,Inconclusive,18860839.0,4221.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
193,1768,1,1,,26748554,3884,Inconclusive,56550039.0,4297.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
194,1768,1,1,,50107431,3884,Inconclusive,18860839.0,4221.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
195,1768,1,1,,50107431,3884,Inconclusive,56550039.0,4297.0,25.1189,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
196,1865,1,1,,26748554,3884,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
197,1865,1,1,,50107431,3884,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
198,1948,1,1,,26748554,3884,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
199,2101,1,1,,26748554,3884,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
200,2101,1,1,,50107431,3884,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
201,2107,1,1,,26748554,3884,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
202,2107,1,1,,50107431,3884,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
203,2112,1,1,,26748554,3884,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
204,2112,1,1,,50107431,3884,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
205,2147,1,1,,26748554,3884,Inconclusive,221046486.0,,31.6228,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
206,2147,1,1,,50107431,3884,Inconclusive,221046486.0,,25.1189,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
207,2451,1,2,,26748554,3884,Active,122920737.0,,1.7741,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
208,2451,1,2,,50107431,3884,Active,122920737.0,,1.1194,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
209,2472,1,2,,26748554,3884,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
210,2472,1,2,,50107431,3884,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
211,2517,2,1,,26748554,3884,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
212,2517,2,1,,50107431,3884,Inconclusive,6980812.0,,4.4668,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
213,2528,1,2,,26748554,3884,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
214,2528,1,2,,50107431,3884,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
215,2546,1,1,,26748554,3884,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
216,2546,1,1,,50107431,3884,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
217,2549,1,1,,26748554,3884,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
218,2549,1,1,,50107431,3884,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
219,2551,1,1,,26748554,3884,Inconclusive,188536040.0,19885.0,35.4813,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
220,2551,1,1,,50107431,3884,Inconclusive,188536040.0,19885.0,3.1623,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
221,74123,4,1,,103178328,3884,Unspecified,,,26915300000.0,Ki,Inhibition constant of compound against binding of Yeast Glyoxalase I,Confirmatory,3290487.0,
222,95651,5,1,,103178328,3884,Unspecified,,,,,Evaluated for cytotoxicity in the KB cell culture assay,Other,3669007.0,
223,115271,3,5,,103178328,3884,Unspecified,,,,,"Tested for its ability to eliminate the infective trypomastigote form of Trypanosoma cruzi, Y strain present in blood of infected mice at the dose of 0.21 mM",Other,,
224,158816,3,3,,103178328,3884,Unspecified,,,,,Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 1),Other,14980653.0,
225,158817,3,3,,103178328,3884,Unspecified,,,,,Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (expt 2),Other,14980653.0,
226,158818,6,2,,103178328,3884,Unspecified,,,,,Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 200 mg/kg peroral dose (experiment 3); Not determined,Other,14980653.0,
227,277223,6,2,,103178328,3884,Active,,,3.18,IC50,Cytotoxicity against human promyelocytic leukemia HL60 cell line by MTT assay,Confirmatory,17249647.0,
228,277224,3,4,,103178328,3884,Unspecified,,,,,"Partition coefficient, log P of the compound",Other,17249647.0,
229,303292,3,4,,103178328,3884,Unspecified,,,,,Inhibition of TPA-induced EBV-EA activation in Raji cells at 1000 mol ratio/TPA relative to control,Other,17950604.0,
230,303293,3,4,,103178328,3884,Unspecified,,,,,Inhibition of TPA-induced EBV-EA activation in Raji cells at 500 mol ratio/TPA relative to control,Other,17950604.0,
231,303294,3,4,,103178328,3884,Unspecified,,,,,Inhibition of TPA-induced EBV-EA activation in Raji cells at 100 mol ratio/TPA relative to control,Other,17950604.0,
232,303295,3,4,,103178328,3884,Unspecified,,,,,Inhibition of TPA-induced EBV-EA activation in Raji cells at 10 mol ratio/TPA relative to control,Other,17950604.0,
233,303296,6,2,,103178328,3884,Unspecified,,,311.4,IC50,Inhibition of TPA-induced EBV-EA activation in Raji cells,Confirmatory,17950604.0,
234,303297,3,4,,103178328,3884,Unspecified,,,,,Cell viability in Raji cells at 1000 mol ratio/TPA by tryptan blue staining relative to control,Other,17950604.0,
235,303298,3,4,,103178328,3884,Unspecified,,,,,Cell viability in Raji cells at 500 mol ratio/TPA by tryptan blue staining relative to control,Other,17950604.0,
236,303299,3,4,,103178328,3884,Unspecified,,,,,Cell viability in Raji cells at 100 mol ratio/TPA by tryptan blue staining relative to control,Other,17950604.0,
237,303300,3,4,,103178328,3884,Unspecified,,,,,Cell viability in Raji cells at 10 mol ratio/TPA by tryptan blue staining relative to control,Other,17950604.0,
238,324605,6,2,,103178328,3884,Active,,,31.3,IC50,Growth inhibition of Trypanosoma cruzi Tulahuen epimastigotes assessed as drug level causing decrease in growth constant,Confirmatory,18029184.0,
239,324606,3,3,,103178328,3884,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma cruzi Tulahuen assessed as trypomastigote viability at 31.3 uM by MTT assay relative to control,Other,18029184.0,
240,324607,3,3,,103178328,3884,Unspecified,,,,,Effect on oxygen uptake per mg of protein in Trypanosoma cruzi Tulahuen epimastigotes relative to control,Other,18029184.0,
241,324608,3,3,,103178328,3884,Unspecified,,,,,Effect on oxygen redox cycling in Trypanosoma cruzi Tulahuen assessed as oxygen consumption per mg of protein relative to control,Other,18029184.0,
242,333842,6,1,,103178328,3884,Inconclusive,,,,,Cytotoxicity against human KB cells,Other,7130986.0,
243,337793,6,3,,103178328,3884,Unspecified,,,,,Cytotoxicity against mouse P388 cells,Other,1791483.0,
244,380856,6,2,,103178328,3884,Unspecified,,,10.0,IC50,Antiproliferative activity against human HaCaT cells,Confirmatory,10479319.0,
245,380857,4,4,,103178328,3884,Inconclusive,,,,,Cytotoxicity against human HaCaT cells assessed as LDH release at 2 uM,Other,10479319.0,
246,382236,6,2,,103178328,3884,Unspecified,,,410.8,IC50,Trypanocidal activity against Trypanosoma cruzi Y blood stream trypomastigotes after 24 hrs,Confirmatory,18378461.0,
247,389437,4,4,,103178328,3884,Active,,,0.06459,IC50,Anticancer activity against human DU145 cells after 72 hrs by XTT assay,Confirmatory,18829316.0,
248,389438,3,4,,103178328,3884,Unspecified,,,,,Anticancer activity against human DU145 cells after 72 hrs 25 ug/ml by XTT assay,Other,18829316.0,
249,400160,5,1,,103178328,3884,Unspecified,,,,,Cytotoxicity against human KB cells,Other,7153777.0,
250,451329,5,2,,103178328,3884,Active,,,1.97,EC50,Antiproliferative activity against human PC3 cells after 72 hrs by trypan blue exclusion assay,Confirmatory,19674905.0,
251,451330,5,2,,103178328,3884,Active,,,4.78,EC50,Antiproliferative activity against human A549 cells after 72 hrs by trypan blue exclusion assay,Confirmatory,19674905.0,
252,451331,5,2,,103178328,3884,Active,,,10.15,EC50,Antiproliferative activity against human MCF7 cells after 72 hrs by trypan blue exclusion assay,Confirmatory,19674905.0,
253,451338,3,4,,103178328,3884,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA induction at 1000 molar ratio after 48 hrs by immunofluorescence technique relative to 12-O-tetradecanoylphorbol-13-acetate,Other,19674905.0,
254,451339,3,4,,103178328,3884,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA induction at 500 molar ratio after 48 hrs by immunofluorescence technique relative to 12-O-tetradecanoylphorbol-13-acetate,Other,19674905.0,
255,451340,3,4,,103178328,3884,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA induction at 100 molar ratio after 48 hrs by immunofluorescence technique relative to 12-O-tetradecanoylphorbol-13-acetate,Other,19674905.0,
256,451341,3,4,,103178328,3884,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA induction at 10 molar ratio after 48 hrs by immunofluorescence technique relative to 12-O-tetradecanoylphorbol-13-acetate,Other,19674905.0,
257,451342,5,2,,103178328,3884,Unspecified,,,311.4,IC50,Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells after 48 hrs by immunofluorescence technique,Confirmatory,19674905.0,
258,451343,3,4,,103178328,3884,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio after 48 hrs by trypan blue staining,Other,19674905.0,
259,451344,3,4,,103178328,3884,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio after 48 hrs by trypan blue staining,Other,19674905.0,
260,476712,5,2,,103178328,3884,Active,,,1.9,GI50,Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay,Confirmatory,20304655.0,
261,476713,5,3,,103178328,3884,Active,,,7.8,GI50,Growth inhibition of human HBL100 cells after 48 hrs by sulforhodamine B assay,Confirmatory,20304655.0,
262,476714,5,2,,103178328,3884,Active,,,2.3,GI50,Growth inhibition of human HeLa cells after 48 hrs by sulforhodamine B assay,Confirmatory,20304655.0,
263,476715,5,2,,103178328,3884,Active,,,34.0,GI50,Growth inhibition of human SW1573 cells after 48 hrs by sulforhodamine B assay,Confirmatory,20304655.0,
264,476716,5,2,,103178328,3884,Unspecified,,,76.0,GI50,Growth inhibition of human T47D cells after 48 hrs by sulforhodamine B assay,Confirmatory,20304655.0,
265,476717,5,2,,103178328,3884,Active,,,36.0,GI50,Growth inhibition of human WiDr cells after 48 hrs by sulforhodamine B assay,Confirmatory,20304655.0,
266,476718,3,3,,103178328,3884,Unspecified,,,,,Toxicity in Artemia salina,Other,20304655.0,
267,481798,5,2,,103178328,3884,Unspecified,,,410.8,IC50,Antitrypanosomal activity against Trypanosoma cruzi Y blood stream trypomastigotes after 24 hrs,Confirmatory,20378360.0,
268,481799,5,2,,103178328,3884,Active,,,2.1,IC50,Cytotoxicity against human PBMC after 72 hrs by alamar blue assay,Confirmatory,20378360.0,
269,485281,1,1,,26748554,3884,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
270,485290,1,1,,26748554,3884,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
271,485290,1,1,,50107431,3884,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
272,485350,1,2,,92124270,3884,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
273,492967,1,2,,99301682,3884,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
274,493033,1,2,,92124270,3884,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
275,493162,1,2,,99301682,3884,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
276,504327,1,1,,26748554,3884,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
277,504332,1,1,,26748554,3884,Inconclusive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
278,504770,1,2,,92124270,3884,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
279,504847,1,1,,26748554,3884,Active,63054845.0,7421.0,35.4813,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
280,504847,1,1,,50107431,3884,Active,63054845.0,7421.0,25.1189,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
281,504865,1,1,,26748554,3884,Active,118600387.0,7398.0,35.4813,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
282,540299,1,2,,92124270,3884,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
283,588519,1,2,,92124270,3884,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
284,588579,1,1,,26748554,3884,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
285,602314,1,2,,92124270,3884,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
286,602332,1,1,,26748554,3884,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
287,618758,4,1,,103178328,3884,Unspecified,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 9 days by resazurin reduction assay,Other,21820768.0,
288,618759,4,1,,103178328,3884,Unspecified,,,,,Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis ATCC 35338 harboring His-526-Tri mutation in rpoB gene after 9 days by resazurin reduction assay,Other,21820768.0,
289,618760,4,1,,103178328,3884,Unspecified,,,,,Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis ATCC 35822 harboring Ser-315-Tri mutation in katG gene after 9 days by resazurin reduction assay,Other,21820768.0,
290,618761,3,2,,103178328,3884,Unspecified,,,103.19,IC50,Cytotoxicity against human PBMC after 72 hrs by Alamar blue assay,Confirmatory,21820768.0,
291,624349,1,2,,92124270,3884,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
292,651631,4,1,,144210146,3884,Active,269849759.0,7157.0,1.5262,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
293,651632,4,1,,144210146,3884,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
294,651633,4,1,,144210146,3884,Inconclusive,,,1.5262,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
295,651634,4,1,,144210146,3884,Active,,,54.1504,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
296,660266,2,2,,103178328,3884,Unspecified,,,410.8,IC50,Trypanocidal activity against bloodstream form of Trypanosoma cruzi Y isolated from albino mouse blood after 24 hrs by neubauer chamber analysis,Confirmatory,22483633.0,
297,663955,3,6,,103178328,3884,Active,68068087.0,2859.0,2.84,EC50,Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay,Confirmatory,24900447.0,
298,663956,3,6,,103178328,3884,Active,68068087.0,2859.0,47.9,EC50,Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay,Confirmatory,24900447.0,
299,663960,5,5,,103178328,3884,Active,68068087.0,2859.0,4.66,IC50,Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins,Confirmatory,24900447.0,
300,663961,1,8,,103178328,3884,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human HT-29 cells assessed as shift in resonant wavelength of biosensor stimulation after 10 mins by dynamic mass redistribution assay relative to control,Other,24900447.0,
301,663962,1,8,,103178328,3884,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay relative to control,Other,24900447.0,
302,663964,1,8,,103178328,3884,Inactive,68068087.0,2859.0,,,Agonist activity at GPR35 receptor in human HT-29 cells at 8 uM after 10 mins by dynamic mass redistribution assay in the presence of SPB05142,Other,24900447.0,
303,665099,2,3,,103178328,3884,Active,,,7.8,GI50,Growth inhibition of human HBL100 cells by SRB assay,Confirmatory,22560628.0,
304,665100,2,2,,103178328,3884,Active,,,2.3,GI50,Growth inhibition of human HeLa cells by SRB assay,Confirmatory,22560628.0,
305,665101,2,2,,103178328,3884,Active,,,34.0,GI50,Growth inhibition of human SW1573 cells by SRB assay,Confirmatory,22560628.0,
306,665102,2,2,,103178328,3884,Active,,,36.0,GI50,Growth inhibition of human WiDr cells by SRB assay,Confirmatory,22560628.0,
307,686978,1,1,,26748554,3884,Inconclusive,79154014.0,55775.0,25.929000000000002,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
308,686978,1,1,,50107431,3884,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
309,686979,1,1,,26748554,3884,Inconclusive,79154014.0,55775.0,29.0929,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
310,686979,1,1,,50107431,3884,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
311,714729,3,1,,103178328,3884,Unspecified,,,,,Metabolic stability in in Wistar rat plasma assessed as alpha-lapachone level at 25 mg/kg after 12 hrs,Other,22796040.0,
312,714730,3,1,,103178328,3884,Unspecified,,,,,Metabolic stability in in Wistar rat plasma assessed as dehydro-alpha-lapachone level at 25 mg/kg after 1.5 hrs,Other,22796040.0,
313,714731,3,1,,103178328,3884,Unspecified,,,,,Metabolic stability in in Wistar rat plasma assessed as alpha-lapachone level at 25 mg/kg after 1.5 hrs,Other,22796040.0,
314,714732,3,1,,103178328,3884,Unspecified,,,,,Metabolic stability in in Wistar rat plasma assessed as alpha-lapachone level at 25 mg/kg after 3 hrs,Other,22796040.0,
315,714733,3,1,,103178328,3884,Unspecified,,,,,Plasma concentration in Wistar rat at 25 mg/kg after 12 hrs,Other,22796040.0,
316,714734,3,1,,103178328,3884,Unspecified,,,,,Plasma concentration in Wistar rat at 25 mg/kg after 1.5 hrs,Other,22796040.0,
317,714735,1,2,,103178328,3884,Unspecified,,,,,Toxicity in Wistar rat at 25 mg/kg,Other,22796040.0,
318,720516,2,1,,144210146,3884,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
319,720532,1,1,,26748554,3884,Active,420597.0,,5.0119,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
320,720532,1,1,,50107431,3884,Inconclusive,420597.0,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
321,720533,1,1,,26748554,3884,Inconclusive,,,3.5481,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
322,720533,1,1,,50107431,3884,Inconclusive,,,25.1189,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
323,720552,2,1,,144210146,3884,Active,269849759.0,7157.0,2.0746,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
324,720579,2,1,,26748554,3884,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
325,720580,1,1,,26748554,3884,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
326,720634,2,1,,144210146,3884,Active,,,54.1504,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
327,720635,2,1,,144210146,3884,Active,,,24.1881,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
328,720637,2,1,,144210146,3884,Active,,,26.1177,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
329,720674,2,2,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
330,720675,2,2,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
331,720678,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
332,720679,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
333,720680,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
334,720681,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
335,720682,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
336,720683,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
337,720684,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
338,720685,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
339,720686,2,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
340,720687,2,2,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
341,720691,4,1,,144210146,3884,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
342,720692,3,1,,144210146,3884,Inconclusive,311348376.0,2908.0,1.9389,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
343,720693,3,1,,144210146,3884,Inconclusive,,,0.2175,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
344,720717,1,3,,92124270,3884,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
345,720719,2,1,,144210146,3884,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
346,720725,2,1,,144210146,3884,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
347,723185,1,2,,103178328,3884,Unspecified,,,410.8,IC50,Antitrypanosomal activity against Trypanosoma cruzi Y bloodstream trypomastigotes isolated from infected Swiss mouse blood assessed as lysis level after 24 hrs,Confirmatory,23279867.0,
348,735529,1,3,,103178328,3884,Active,,,24.1,IC50,Cytotoxicity against human WHCO1 cells after 24 hrs by MTT assay,Confirmatory,23353747.0,
349,743012,3,1,,144210146,3884,Inconclusive,,,76.4895,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
350,743014,3,1,,144210146,3884,Active,,,48.2616,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
351,743015,3,1,,144210146,3884,Active,,,60.7578,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
352,743033,3,1,,144210146,3884,Inconclusive,,,1.5401,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
353,743035,2,1,,144210146,3884,Inconclusive,124375976.0,367.0,17.2804,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
354,743036,2,1,,144210146,3884,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
355,743040,3,1,,144210146,3884,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
356,743041,3,1,,144210146,3884,Inconclusive,,,54.1504,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
357,743042,3,1,,144210146,3884,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
358,743053,2,1,,144210146,3884,Inconclusive,124375976.0,367.0,11.5492,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
359,743054,2,1,,144210146,3884,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
360,743063,2,1,,144210146,3884,Inconclusive,124375976.0,367.0,3.44789,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
361,743064,3,1,,144210146,3884,Inconclusive,,,96.2946,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
362,743065,3,1,,144210146,3884,Active,399498506.0,24831.0,0.1712,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
363,743066,3,1,,144210146,3884,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
364,743067,2,1,,144210146,3884,Inconclusive,399498506.0,24831.0,0.171239,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
365,743069,2,1,,144210146,3884,Inconclusive,348019627.0,2099.0,24.4092,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
366,743074,2,1,,144210146,3884,Inconclusive,,,0.0546,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
367,743075,2,1,,144210146,3884,Inconclusive,348019627.0,2099.0,48.7027,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
368,743077,2,1,,144210146,3884,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
369,743078,2,1,,144210146,3884,Inconclusive,348019627.0,2099.0,0.567832,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
370,743079,3,1,,144210146,3884,Inconclusive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
371,743080,3,1,,144210146,3884,Inconclusive,348019627.0,2099.0,30.451,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
372,743081,3,1,,144210146,3884,Active,,,54.1504,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
373,743083,3,1,,144210146,3884,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
374,743084,3,1,,144210146,3884,Inconclusive,,,54.1504,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
375,743085,3,1,,144210146,3884,Active,51095037.0,196.0,54.1504,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
376,743086,3,1,,144210146,3884,Inconclusive,,,38.3356,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
377,743091,2,1,,144210146,3884,Inconclusive,348019627.0,2099.0,30.451,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
378,743094,3,1,,144210146,3884,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
379,743122,2,1,,144210146,3884,Active,51095037.0,196.0,23.2774,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
380,743139,2,1,,144210146,3884,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
381,743140,2,1,,144210146,3884,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
382,743191,3,1,,144210146,3884,Active,216409692.0,5468.0,0.7719,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
383,743194,3,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
384,743199,2,1,,144210146,3884,Active,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
385,743202,4,1,,144210146,3884,Inconclusive,20149576.0,4780.0,68.1713,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
386,743203,3,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
387,743209,3,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
388,743210,4,1,,144210146,3884,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
389,743211,3,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
390,743212,3,1,,144210146,3884,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
391,743213,3,1,,144210146,3884,Inconclusive,,,1.0903,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
392,743215,3,1,,144210146,3884,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
393,743217,3,1,,144210146,3884,Inconclusive,325495553.0,9971.0,1.0903,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
394,743218,3,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
395,743219,3,1,,144210146,3884,Active,20149576.0,4780.0,57.358999999999995,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
396,743220,3,1,,144210146,3884,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
397,743221,3,1,,144210146,3884,Inconclusive,,,1.5401,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
398,743222,3,1,,144210146,3884,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
399,743223,3,1,,144210146,3884,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
400,743224,3,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
401,743225,3,1,,144210146,3884,Inconclusive,,,4.8703,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
402,743226,2,1,,144210146,3884,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
403,743227,2,1,,144210146,3884,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
404,743228,3,1,,144210146,3884,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
405,743239,2,1,,144210146,3884,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
406,743240,2,1,,144210146,3884,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
407,743241,2,1,,144210146,3884,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
408,743242,2,1,,144210146,3884,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
409,744764,1,1,,103178328,3884,Unspecified,,,,,"Selectivity index, ratio of CC50 for Swiss mouse peritoneal macrophages to IC50 for antimony-resistant Leishmania amazonensis MHOM/BR/1989/BA199 promastigote",Other,23535320.0,
410,744765,1,1,,103178328,3884,Unspecified,,,,,"Selectivity index, ratio of CC50 for Swiss mouse peritoneal macrophages to IC50 for antimony-sensitive Leishmania amazonensis MHOM/BR/1989/BA199 promastigote",Other,23535320.0,
411,744766,1,1,,103178328,3884,Unspecified,,,,,"Selectivity index, ratio of CC50 for Swiss mouse peritoneal macrophages to IC50 for antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote",Other,23535320.0,
412,744767,1,1,,103178328,3884,Unspecified,,,,,"Selectivity index, ratio of CC50 for Swiss mouse peritoneal macrophages to IC50 for antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote",Other,23535320.0,
413,744768,1,1,,103178328,3884,Unspecified,,,59.3,CC50,Cytotoxicity against Swiss mouse peritoneal macrophages after 24 hrs by MTT assay,Confirmatory,23535320.0,
414,744769,1,1,,103178328,3884,Unspecified,,,63.28,IC50,Antileishmanial activity against antimony-resistant Leishmania amazonensis MHOM/BR/1989/BA199 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,Confirmatory,23535320.0,
415,744770,1,1,,103178328,3884,Unspecified,,,102.05,IC50,Antileishmanial activity against antimony-sensitive Leishmania amazonensis MHOM/BR/1989/BA199 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,Confirmatory,23535320.0,
416,744771,1,1,,103178328,3884,Unspecified,,,99.88,IC50,Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,Confirmatory,23535320.0,
417,744772,1,1,,103178328,3884,Active,,,34.72,IC50,Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,Confirmatory,23535320.0,
418,977599,1,1,,103178328,3884,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
419,977602,1,2,,103178328,3884,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
420,1064150,1,2,,103178328,3884,Active,,,9.0,IC50,Growth inhibition of human LoVo cells by MTT assay,Confirmatory,24374273.0,
421,1064151,1,1,,103178328,3884,Active,,,4.0,IC50,Growth inhibition of human PC3 cells by MTT assay,Confirmatory,24374273.0,
422,1064152,1,2,,103178328,3884,Active,,,8.0,IC50,Growth inhibition of human SK-MEL-28 cells by MTT assay,Confirmatory,24374273.0,
423,1064153,1,1,,103178328,3884,Active,,,11.0,IC50,Growth inhibition of human Hs683 cells by MTT assay,Confirmatory,24374273.0,
424,1064154,1,1,,103178328,3884,Active,,,8.0,IC50,Growth inhibition of human U373 cells by MTT assay,Confirmatory,24374273.0,
425,1064155,1,2,,103178328,3884,Active,,,8.0,IC50,Growth inhibition of human A549 cells by MTT assay,Confirmatory,24374273.0,
426,1079960,1,1,,103178328,3884,Unspecified,,,,,Toxicity against Trichoplusia ni (cabbage looper) third-instar larvae stage assessed as mortality at 10 ug/ml for 24 hr by topical application,Other,23731643.0,
427,1079962,1,1,,103178328,3884,Unspecified,,,,,Antifeedant activity against Trichoplusia ni (cabbage looper) third-instar larvae stage assessed as feeding deterrence index at 50 microg/cm'2 by feeding deterrent bioassay,Other,23731643.0,
428,1085649,1,2,,103178328,3884,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis by Bactec TB-460 assay,Other,,
429,1085650,3,1,,103178328,3884,Unspecified,,,,,Antibacterial activity against Bacillus cereus after 24 hr by p-iodonitrotetrazolium assay,Other,,
430,1085651,3,1,,103178328,3884,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus after 24 hr by p-iodonitrotetrazolium assay,Other,,
431,1085652,3,1,,103178328,3884,Unspecified,,,,,Antibacterial activity against Escherichia coli after 24 hr by p-iodonitrotetrazolium assay,Other,,
432,1114571,1,2,,103178328,3884,Active,,,,,"Antidepressant activity in albino Mus musculus (mouse) assessed as reduction in immobility time at 50 mg/kg, ip administered 30 min prior to testing by forced-swim test relative to control",Other,,
433,1114573,1,2,,103178328,3884,Unspecified,,,,,"Stimulation of central nervous system in albino Mus musculus (mouse) assessed as increase in rearing behaviour at 100 mg/kg, ip administered 30 min prior to testing by open-feild test relative to control",Other,,
434,1114575,1,2,,103178328,3884,Unspecified,,,,,"Stimulation of central nervous system in albino Mus musculus (mouse) assessed as increase in number of lines crossed at 100 mg/kg, ip administered 30 min prior to testing by open-feild test relative to control",Other,,
435,1114576,1,2,,103178328,3884,Active,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in number of open arm enteries at 100 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
436,1114577,1,2,,103178328,3884,Active,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in number of open arm enteries at 50 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
437,1114578,1,2,,103178328,3884,Inactive,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in time spent on open arm at 100 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
438,1114580,1,2,,103178328,3884,Inactive,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in time spent on open arm at 50 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
439,1159509,1,1,,144210146,3884,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
440,1159515,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
441,1159516,1,1,,144210146,3884,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
442,1159517,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
443,1159518,1,1,,144210146,3884,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
444,1159519,1,1,,144210146,3884,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
445,1159520,1,1,,144210146,3884,Inconclusive,,,24.1881,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
446,1159521,1,1,,144210146,3884,Active,15928672.0,19885.0,13.602,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
447,1159523,1,1,,144210146,3884,Active,15928672.0,19885.0,15.2617,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
448,1159524,1,1,,26748554,3884,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
449,1159524,1,1,,50107431,3884,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
450,1159525,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
451,1159526,1,1,,144210146,3884,Inconclusive,119627033.0,3725.0,30.7293,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
452,1159527,1,1,,144210146,3884,Inconclusive,325495497.0,6256.0,3.4479,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
453,1159528,1,1,,144210146,3884,Inconclusive,119627033.0,3725.0,0.8660709999999999,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
454,1159529,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
455,1159531,1,1,,144210146,3884,Active,325495497.0,6256.0,3.44789,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
456,1159550,3,1,,252402717,3884,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
457,1159551,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
458,1159552,1,1,,144210146,3884,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
459,1159553,2,1,,144210146,3884,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
460,1159555,1,1,,144210146,3884,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
461,1159580,2,1,,268735813,3884,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
462,1224834,3,1,,144210146,3884,Inconclusive,,,48.2616,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
463,1224835,1,1,,144210146,3884,Inconclusive,160794.0,,79.2511,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
464,1224836,1,1,,144210146,3884,Inconclusive,,,48.2616,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
465,1224837,1,1,,144210146,3884,Inconclusive,,,48.2616,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
466,1224838,1,1,,144210146,3884,Inactive,66775687.0,9970.0,60.7578,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
467,1224839,1,1,,144210146,3884,Active,66775687.0,9970.0,27.1395,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
468,1224840,3,1,,144210146,3884,Inconclusive,,,43.0132,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
469,1224841,3,1,,144210146,3884,Active,325495545.0,2101.0,2.4188,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
470,1224842,3,1,,144210146,3884,Inactive,325495545.0,2101.0,2.4188,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
471,1224843,1,1,,144210146,3884,Inconclusive,119601739.0,7253.0,24.1881,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
472,1224844,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
473,1224845,1,1,,144210146,3884,Inconclusive,344243002.0,100757539.0,50.2004,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
474,1224846,1,1,,144210146,3884,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
475,1224847,1,1,,144210146,3884,Inconclusive,,,126.098,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
476,1224848,3,1,,144210146,3884,Active,325495545.0,2101.0,1.9213,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
477,1224849,3,1,,144210146,3884,Inactive,325495545.0,2101.0,1.7124,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
478,1224867,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
479,1224868,1,1,,144210146,3884,Inconclusive,,,34.4789,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
480,1224869,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
481,1224870,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
482,1224871,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
483,1224872,1,1,,144210146,3884,Inconclusive,,,38.686,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
484,1224873,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
485,1224874,1,1,,144210146,3884,Active,,,24.4092,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
486,1224875,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
487,1224876,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
488,1224877,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
489,1224878,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
490,1224879,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
491,1224880,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
492,1224881,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
493,1224882,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
494,1224883,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
495,1224884,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
496,1224885,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
497,1224886,1,1,,144210146,3884,Inconclusive,,,38.686,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
498,1224887,1,1,,144210146,3884,Inconclusive,,,24.4092,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
499,1224888,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
500,1224889,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
501,1224890,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
502,1224892,1,1,,144210146,3884,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
503,1224893,1,1,,144210146,3884,Inconclusive,66775687.0,9970.0,60.7578,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
504,1224894,1,1,,144210146,3884,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
505,1224895,1,1,,144210146,3884,Active,119601739.0,7253.0,30.451,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
506,1224896,1,1,,144210146,3884,Inconclusive,344243002.0,100757539.0,75.1116,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
507,1259241,1,1,,144210146,3884,Inconclusive,,,43.0132,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
508,1259242,1,1,,144210146,3884,Inconclusive,,,54.1504,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
509,1259243,1,1,,144210146,3884,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
510,1259244,1,1,,144210146,3884,Inconclusive,348019627.0,2099.0,4.8262,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
511,1259247,1,1,,144210146,3884,Inconclusive,124375976.0,367.0,48.2616,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
512,1259248,1,1,,144210146,3884,Active,348019627.0,2099.0,11.2271,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
513,1259310,1,1,,333494727,3884,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
514,1259364,1,1,,144210146,3884,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
515,1259365,1,1,,144210146,3884,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
516,1259366,1,1,,144210146,3884,Inconclusive,,,68.1713,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
517,1259367,1,1,,144210146,3884,Inconclusive,,,30.451,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
518,1259368,1,1,,144210146,3884,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
519,1259369,1,1,,144210146,3884,Inconclusive,109731339.0,2737.0,68.1713,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
520,1259377,1,1,,144210146,3884,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
521,1259378,1,1,,144210146,3884,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
522,1259379,1,1,,144210146,3884,Active,,,43.0132,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
523,1259380,1,1,,144210146,3884,Active,,,1.5262,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
524,1259381,1,1,,144210146,3884,Inconclusive,124375976.0,367.0,24.1881,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
525,1259382,1,1,,144210146,3884,Inconclusive,,,10.8044,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
526,1259383,1,1,,144210146,3884,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
527,1259384,1,1,,144210146,3884,Inconclusive,,,60.7578,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
528,1259385,1,1,,144210146,3884,Inconclusive,119601739.0,7253.0,68.1713,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
529,1259386,1,1,,144210146,3884,Active,,,43.0132,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
530,1259387,1,1,,144210146,3884,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
531,1259388,1,1,,144210146,3884,Inconclusive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
532,1259389,1,1,,124633319,3884,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
533,1259390,1,1,,144210146,3884,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
534,1259391,1,1,,144210146,3884,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
535,1259392,1,1,,144210146,3884,Inconclusive,109731339.0,2737.0,27.1395,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
536,1259393,1,1,,144210146,3884,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
537,1259394,1,1,,144210146,3884,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
538,1259395,1,1,,144210146,3884,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
539,1259396,1,1,,144210146,3884,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
540,1259401,1,1,,144210146,3884,Active,325495545.0,2101.0,3.6892199999999997,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
541,1259402,1,1,,144210146,3884,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
542,1259403,1,1,,144210146,3884,Active,325495545.0,2101.0,1.52617,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
543,1259404,1,1,,144210146,3884,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
544,1259407,1,1,,363898695,3884,Inactive,,,,,CCRIS mutagenicity studies,Other,,
545,1259423,1,2,,354772058,3884,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
